Drug Type AAV based gene therapy |
Synonyms |
Target |
Mechanism TREM2 modulators(Triggering receptor expressed on myeloid cells 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hereditary Diffuse Leukoencephalopathy With Spheroids | Preclinical | US | 23 Apr 2024 |